Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      BoomerangFX Launches ChatGPT AI Search Advertising for Aesthetic, Wellness and Private-Pay Healthcare Practices, Powered by AUVIA™ AI Clinic Co-Pilot

      This image opens in the lightbox

      News provided by

      BoomerangFX

      17 Nov, 2026, 15:03 GMT

      Share this article

      Share this article


      New offering connects paid search advertising on OpenAI's ChatGPT with AI search optimization for Claude and Gemini, linking lead generation, conversion, practice management workflow and payments in one platform. Initial rollout in the USA, Canada and UK, with expansion planned across Ireland, Germany, Australia, India and Latin America.

      MIAMI and TORONTO and LONDON and SYDNEY, Nov. 17, 2026 /PRNewswire/ -- BoomerangFX, the global AI-powered clinic software and marketing automation company purpose-built for private-pay healthcare, today announced the launch of its next-generation AI Search Marketing offering. Rolling out first in the USA, Canada and UK beginning November 2026, the launch brings AI Search Advertising on OpenAI's ChatGPT and Search Optimization Intelligence for Claude and Gemini into its GROW SaaS product suite, enhanced by AUVIA™, the AI Clinic Co-Pilot, connecting patient inquiries to conversion and end-to-end clinic practice management.

      Continue Reading
      This image opens in the lightbox
      BoomerangFX Expands into AI Search Advertising, Helping Healthcare Practices Reach Prospective Patients Through AI-Powered Search Platforms. (CNW Group/BoomerangFX)

      BoomerangFX describes the offering as the world's first specialty AI search marketing platform to connect ChatGPT ad campaigns, optimization for Claude and Gemini, and agentic patient engagement with integrated electronic medical records, scheduling and payments. The offering is available through GROW Platinum upgrade for existing and new clients.

      A New Era of Patient Discovery: AI Assistants Become the Front Door to Care

      AI assistants are fast becoming a starting point for treatment research by prospective shoppers for aesthetic and wellness treatments. According to an August 2026 Pew Research Center report, 34% of U.S. adults now use AI chatbots for at least one health or medical reason. BoomerangFX helps practices build visibility in these emerging discovery channels and convert that interest into booked consultations.

      "The next era of clinic growth will be shaped by how effectively practices turn AI discovery into lasting patient relationships," said Jerome Dwight, Co-Founder & CEO of BoomerangFX. "We are bringing advertising, search visibility, patient conversations and clinical operations into one platform, helping clinics connect the demand they create with the experience they deliver."

      Smart Website Intelligence: Making AI Discovery Actionable

      The GROW product suite's Smart Website Intelligence provides the foundation for AI discoverability, organizing treatment expertise, clinician credentials, practice locations and patient education into clear, accessible website content. Search Optimization Intelligence applies BoomerangFX's proprietary data science to help AI platforms discover, interpret and reference that information when prospective patients research care.

      The offering combines eligible paid AI Search Ads on OpenAI's ChatGPT with website and content optimization for organic discoverability through Claude and Gemini, giving every visitor a clear pathway to inquire, engage and book. For greater discoverability, the Company's multi-platform advertising model also leverages more conventional platforms like Google, Meta and Instagram for maximum reach.

      Additionally, its AI-powered Clinic Co-Pilot AUVIA™'s agentic workflows support immediate lead response and personalized follow-up to move inquiries into booked treatments with minimal manual intervention. Campaign and conversion signals feed ongoing optimization, linking marketing activity directly to patient engagement and booking outcomes.

      The BoomerangFX Platform: One System From First Inquiry to Lifetime Patient Care

      BoomerangFX connects this new channel to three integrated solutions:

      • RUN: The all-in-one practice management and EMR foundation. Scheduling, digital charting, consents, treatment records, e-prescribing, inventory and reporting connect with billing, payments and patient financing, while memberships, packages and rebooking sustain long-term patient relationships. The Company's product roadmap includes agentic workflows inside the system of record to drive clinic optimization and task management for busy clinics.

      • GROW: Lead capture, pipeline management, Smart Website Intelligence and conversion workflows. Once demand is created through optimized advertising campaigns, AUVIA™, its specialized multi-LLM AI Clinic Co-Pilot, engages prospective patients through personalized multilingual chat features, coordinates qualification and consultation booking, supports payment workflows and automates reminders and follow-up.

      • ELEVATE: The firm's specialty marketing strategy and execution generate demand, connecting specialty positioning, intelligent website optimization, campaign development, paid media and ongoing optimization to each practice's growth objectives.

      Together, these solutions carry the relationship from first inquiry through engagement and into RUN for treatment documentation, compliance, payments and ongoing care. Practice owners gain a coordinated operating model designed to improve conversion, reduce missed inquiries and increase the lifetime value of every patient.

      Built on Specialty Data Science and Clinical Expertise

      The launch builds on the BoomerangFX team's experience delivering more than 10,000 Google, Meta and Instagram campaigns over the past decade. Its proprietary machine learning and data science models combine that marketing experience with specialty context and performance analysis to inform campaign development and optimization.

      AUVIA™'s specialty knowledge framework spans in excess of 2,000 specialty treatment and clinical-indication entries, covering procedural nomenclature, treatment modalities and concerns such as cutaneous photodamage, dermal laxity and dyspigmentation. This context supports relevant patient communication, while clinical assessment and treatment selection remain with the practitioner.

      Leadership in Aesthetics Innovation and Clinical Education

      Clinical guidance is informed by BoomerangFX's medical advisory board, led by Dr. Stephen Mulholland, Co-Founder and Chief Clinical Architect of BoomerangFX. A globally recognized cosmetic surgeon, Dr. Mulholland is a co-founder of InMode, where he helped lead its 2019 NASDAQ IPO, co-creator of Morpheus8 and co-developer of BodyTite, FaceTite and AccuTite.

      "Aesthetic and wellness practices need technology that understands the language of their specialties and the expectations of their patients," said Dr. Stephen Mulholland, Co-Founder and Chief Clinical Architect of BoomerangFX. "Connecting specialty-level marketing with responsive communication and a complete clinical record helps practices deliver a more consistent experience from the first question through continuing care."

      Availability: Rollout Beginning November 2026

      The offering launches in November 2026 through its GROW Platinum Tier, beginning in the USA, Canada and UK, with expansion planned across Ireland, Germany, Australia, India and Latin America. Upgrade pathways are available for existing BoomerangFX RUN and GROW clients. The launch extends BoomerangFX's recurring subscription platform across patient acquisition, AI engagement, clinical software and payments.

      ChatGPT ad activation depends on market availability, practice specialty and advertiser approval. Search Optimization Intelligence supports organic discoverability on Claude and Gemini; inclusion, rankings and recommendations remain determined by each platform. Paid placements are separate from AI-generated answers.

      Learn more at boomerangfx.com.

      About BoomerangFX

      BoomerangFX is a global AI-powered clinic software and marketing automation company purpose-built for private-pay healthcare. The company unifies RUN practice management and EMR, GROW patient acquisition and conversion, AUVIA™ AI Clinic Co-Pilot, ELEVATE marketing, embedded payments and LEARN education for aesthetic, wellness and private healthcare practices. BoomerangFX operates in a growing list of international markets, including the USA, Canada, the UK, Ireland, Germany, Australia, India and Latin America. With offices in Miami, Toronto, London and Sydney, BoomerangFX is advancing its mission to become the foundational operating platform for private-pay healthcare worldwide.

      ELEVATE is BoomerangFX's premium specialty healthcare marketing solution, with campaign experience in more than seven countries across medspas, cosmetic surgery, hair restoration, women's health, weight management, longevity and functional medicine. Its international resources span strategy, branding, website design, paid advertising, SEO, social media, content, campaign optimization and performance reporting.

      Modal title

      Also from this source

      BoomerangFX Announces Strategic Partnership with Web Marketing Clinic, Accelerating Growth of Its AI-Powered Clinic Software and Marketing Platform Across the UK and Europe

      BoomerangFX Announces Strategic Partnership with Web Marketing Clinic, Accelerating Growth of Its AI-Powered Clinic Software and Marketing Platform Across the UK and Europe

      Partnership unites the UK's leading specialist aesthetic marketing agency with BoomerangFX's AI-powered clinic operating and marketing technology...

      BoomerangFX's AUVIA™ AI Clinic Co-Pilot Surpasses 1,000 Monthly Autonomous Consultations Amid Rapid Acceleration Across North America, Europe and Asia-Pacific

      BoomerangFX's AUVIA™ AI Clinic Co-Pilot Surpasses 1,000 Monthly Autonomous Consultations Amid Rapid Acceleration Across North America, Europe and Asia-Pacific

      BoomerangFX today announced that its AUVIA™ AI Clinic Co-Pilot has surpassed 1,000 autonomous patient appointment bookings per month, marking a...

      More Releases From This Source

      Explore

      Artificial Intelligence

      Artificial Intelligence

      Computer Software

      Computer Software

      Computer & Electronics

      Computer & Electronics

      Cloud Computing/Internet of Things

      Cloud Computing/Internet of Things

      News Releases in Similar Topics

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.